Metoprolol 100mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Metoprolol tartrate

Available from:

Milpharm Ltd

ATC code:

C07AB02

INN (International Name):

Metoprolol tartrate

Dosage:

100mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02040000; GTIN: 8901175015924

Patient Information leaflet

/THERMEDICINESAND-ETOPROLOL
Tell your doctor or pharmacist if you are taking,
have recently taken or might take any other
medicines of the following:
s
CLONIDINEFORHIGHBLOODPRESSUREORMIGRAINE 
If you are taking clonidine and metoprolol
together, do not stop taking clonidine unless
your doctor has told you to do so. If you have
to stop taking clonidine or metoprolol, your
doctor will give you careful instructions about
how to do it.
s
OTHERDRUGSFORYOURHEARTORTOREDUCEBLOOD
pressure, e.g. prazosin
s
OTHERBETABLOCKERSEGTIMOLOLFORGLAUCOMA
s
MONOAMINE OXIDASEINHIBITORSFORDEPRESSION
e.g. phenelzine
s
VERAPAMILDILTIAZEMHYDRALAZINENIFEDIPINE
(used to treat heart problems)
s
QUINIDINEAMIODARONEFORHEARTPROBLEMS
s
CIMETIDINEUSEDTOTREATHEARTBURN
s
CARDIACGLYCOSIDESEGDIGOXINUSEDTOTREAT
heart failure)
s
RIFAMPICINUSEDTOTREATTUBERCULOSIS
s
LIDOCAINEUSEDASALOCALANAESTHETICTORELIEVE
pain)
s
ERGOTAMINEUSEDTOTREATMIGRAINE
s
MEDICINESTOTREATOTHERMENTALILLNESSESSUCH
as phenothiazines)
s
ANTIRETROVIRALDRUGSEGRITONAVIR USEDTOTREAT
AIDS and some other conditions
s
DRUGSTOPREVENTMALARIA
s
MEDICINESTOTREATFUNGALINFECTIONS
s
ADRENALINEUSEDINEMERGENCYTREATMENTEG
allergic reactions)
s
INDOMETACINANDCELECOXIBUSEDTOTREAT
inflammation of the joints, gout and period
pain) medicines for the treatment of diabetes
(including insulin). Your doctor may need to
adjust your dose of these medicines.
Tell your doctor or pharmacist if you are taking,
have recently taken or might take other
medicines, including medicines obtained without
a prescription.
4AKING-ETOPROLOLWITHFOODDRINKANDALCOHOL
You should keep your alcohol intake to a
minimum while you are taking Metoprolol, as
alcohol may increase the effect of this drug.
0REGNANCYBREAST FEEDINGANDFERTILITY
)FYOUAREPREGNANTORBREAST FEEDINGTHINKYOU
may be pregnant or are planning to have a baby,
ask your doctor or pharmacist for advice before
taking this medicine.
$RIVINGANDUSINGMACHINES
Metoprolol may cause dizziness and tiredness, if
affected do not drive or operate machinery.

Summary of Product characteristics

OBJECT 1
METOPROLOL TARTRATE 100MG FILM-COATED TABLETS
Summary of Product Characteristics Updated 07-Nov-2017 | Aurobindo
Pharma - Milpharm Ltd.
1. Name of the medicinal product
Metoprolol tartrate 100 mg film-coated tablets
2. Qualitative and quantitative composition
Each film-coated tablet contains 100 mg metoprolol tartrate
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablet
Light blue coloured, round shaped [diameter 10.6 mm], film-coated
tablets, debossed with 'C over 75' on
one side and deep score line on the other side.
The tablet can be divided into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Metoprolol tartrate is indicated in adults for:
• Hypertension.
• Angina pectoris.
• Tachycardiac arrhythmia, particularly supraventricular
tachycardia.
• Prevention of cardiac death and re-infarction after the acute
phase of myocardial infarction.
• Prophylaxis of migraine.
4.2 Posology and method of administration
Posology
The dose must always be adjusted to the individual requirements of the
patient but should not exceed 400
mg/day. The following are guidelines:
_Adults:_
Hypertension: Initially 100 mg daily. This may be increased, if
necessary, to 200 mg daily in single or
divided doses. Combination therapy with another antihypertensive agent
may also be considered to
further reduce blood pressure.
Angina pectoris: Usually 50-100 mg twice daily. The dose may be
further increased or combined with
nitrates.
Tachycardiac arrhythmias: A daily dose of 100 -200 mg is usually
sufficient. If necessary the dose may
be increased.
After acute intravenous treatment of myocardial infarction: Orally,
therapy should commence 15 minutes
after the last intravenous injection with 50 mg every 6 hours for 48
hours.
Prophylaxis after myocardial infarction: Maintenance dose is 100 mg
twice daily.
Prophylaxis of migraine: 50-100 mg twice daily.
_Patients with renal impairment_
The rate of elimination is insignificantly affected by renal function
and therefore no dos